Estee Lauder Stock Falls As Puig Deal Ends And Turnaround Plan Takes Center Stage

Estee Lauder Companies Inc. (The) stocks have been trading up by 11.87 percent amid strong earnings-driven investor optimism.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading EL

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

Estée Lauder and Spanish beauty group Puig have ended talks over a potential business combination, with management doubling down on its existing ‘Beauty Reimagined’ and ‘One ELC’ standalone strategy.
Piper Sandler assumed coverage with an Overweight rating and a $95 price target, pointing to improving organic growth, Americas stabilization, and a potential top-line inflection by FY27.
Final bids are in for Too Faced, Smashbox, and Dr. Jart, with a sale decision expected within weeks, signaling active portfolio reshaping and a possible balance-sheet and margin catalyst.
Rothschild & Co Redburn lifted its target to $70 from $65, while the broader Street still sits around $93 and leans overweight, showing ongoing medium-term optimism despite recent volatility.
Shares dropped roughly 4.5–5.3% on heavy volume during earlier Puig-deal uncertainty, underscoring how sensitive traders are to M&A headlines and strategic clarity around EL.

Weekly Update May 18 – May 22, 2026: On Friday, May 22, 2026 Estee Lauder Companies Inc. (The) stock [NYSE: EL] is trending up by 11.87%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Consumer Staples industry expert:

Analyst sentiment – positive

Estée Lauder remains a premium global beauty leader but is operating well below its historical earnings power. A 74% gross margin and Q3 EBIT margin near 7% (vs. 3.9% LTM) confirm strong pricing power and early operating recovery, yet consolidated profit margins remain slightly negative and ROIC is still weak. Revenue has been flat-to-down over 3–5 years, and leverage is elevated (total debt/equity 2.3x, interest cover 4x). Cash generation is a relative bright spot: Q3 free cash flow of ~$310m comfortably covers the dividend, and liquidity is solid with ~$3.1bn cash and a 1.4x current ratio, giving management room to execute restructuring and selective divestitures.

Technically, the stock is transitioning from repair to early uptrend. This week’s move from ~$76 to ~$88, including a wide-range breakout day to $91.34 before closing at $87.29, signals aggressive dip buying after prior M&A-driven volatility. Intraday 5‑minute candles show rising lows and strong volume on upswings, with consolidation above $88 into the close. The dominant trend is now upward, provided $80 holds as a key support pivot. Actionable level: accumulate on pullbacks toward $82–84 with a tight stop below $80, targeting a retest of the $95 area where prior supply and analyst targets cluster.

More Breaking News

Fundamentally and versus Consumer Staples and Household & Personal Care peers, EL still trades rich on sales (~1.9x) and cash flow, but its margin trajectory and brand equity justify a premium as restructuring and portfolio simplification (potential sale of Too Faced, Smashbox, Dr. Jart) progress. Termination of Puig merger talks removes a major overhang and refocuses investors on the “Beauty Reimagined” self-help story, supported by constructive broker sentiment (Overweight ratings, ~$90–95 targets). Near term, I see a favorable risk/reward skew: base case 12–18 month fair value $95–100, with support at $80 and intermediate resistance around $92–95. EL is a buy on weakness for investors willing to underwrite execution risk in China and profitability restoration.

Quick Financial Overview

Estee Lauder Companies Inc. (The) has seen notable price swings around the Puig headlines, but the weekly chart shows a strong rebound. After dipping to about $76 on 2026/05/19, EL pushed to a high near $91 on 2026/05/21 and closed the week around $88.53. That move represents a sharp recovery from the panic around deal uncertainty and tells traders there is real dip demand near the mid-$70s.

On the intraday tape, EL spent most of the day grinding between roughly $86 and $88 before a late push into the close near $88.60. That steady bid, without wild spikes, hints at accumulation rather than pure short-covering. For short-term traders, the $86 zone now looks like first support, while the $90–91 area from the weekly high is the first key resistance to watch for a breakout or rejection.

Fundamentals show a mixed but improving picture. Revenue sits around $14.33B with a strong 74.3% gross margin, yet profit margin is slightly negative at about -1.2%, and returns on equity are also slightly negative on a trailing basis. At the same time, the latest quarter delivered $3712M in revenue, $462M in EBITDA, and $310M in free cash flow, showing that cash generation is ahead of reported earnings. Leverage is high, with total debt to equity at 2.33, but liquidity is reasonable with a current ratio of 1.4, and EL still supports a roughly 1.8% dividend yield.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!